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Tetrapleura tetraptera and Aframomum citratum fruits are used as spices and in the traditional 
pharmacopeia in Cameroon. They are mostly combined and preheated for many purposes while 
cooking. The effects of roasting on the phenolic content of spices, phenolic profile of a beverage made 
with the mix of roasted spices and its hypoglycaemic activity on diabetes complications were 
investigated. Aqueous extract (infusion: 100°C; 1/5 g/ml) was prepared, and the total polyphenols and 
flavonoids contents before and after heat treatment were quantified. Four formulations of T. 
tetraptera/A. citratum (95/5; 90/10; 85/15; 80/20) were assessed and the in vitro glucose adsorption 
capacity of the extracts was studied to retain the most effective formulation (AEF). Phenolic and 
derivatives compounds of AEF were analysed using HPLC-DAD methodology. The AEF hypoglycaemic 
activity (250 mg/kg bw) and the various complications of hyperglycaemia after Streptozotocin induction 
(55 mg/kg) were examined on rats. Significant (p<0.05) improvements in phytochemical content were 
noticed for T. tetraptera and AEF extracts after heat treatment. Among the phenolic compounds 
identified, flavone, protocatechic, chlorogenic, p-Coumaric acids, and naringin showed the highest 
concentrations. Significantly, the effect of AEF is the same as the administration of AEF-Glibenclamide 
(Glibenclamide) and Acarbose after 4h when assessing the anti-hyperglycaemic test. The influence of 
Glibenclamide (the reference drug) is significantly improved by AEF, and this synergy has the best anti-
hyperglycaemic, hypoglycaemic, hypotriglyceridaemic potential and boosts catalase, superoxide 
dismutase activities while reducing Malondialdehyde (liver, pancreas, haemolysates) and 
hydroperoxide (liver, plasma, and kidney) contents compared with the use of single AEF.  
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The fruits of Tetrapleura tetraptera and Aframomum 
citratum were identified (Sneyd, 2013) as being among 
the most commonly used and available spices in 





have multiple folkloric and ethnobotanical uses (anti-
cancer, anti-inflammatory, anti-malarial, anti-convulsive, 
anti-diabetic, etc…) in many Central and West African 
countries (Kemigisha et al., 2018; Djiazet et al., 2016; 
Amadi et al., 2016). T. tetrapterais from the West African 
rainforest (Ogbunugafor et al., 2017) and belongs to the 
class of Magnoliopsida, Fabaceae family while A. 
citratum is part of the Angiosperms, family of 
Zingiberaceae (Amadi et al., 2016). 
Used as spices, A. citratum and T. tetraptera fruits 
undergo heat treatment most of the time before cooking. 
Indeed, they are hard-shelled fruits and thus generally 
roasted for many purposes (to facilitate the grinding and 
release of aroma or to enhance a particular stew colour). 
Mixed together they are roasted prior to use when 
cooking popular recipes in Cameroon like 
“MbongoTchobo” (black stew) from the Littoral Region, 
and “Nkwui” from the west Region. However, processed 
foods have been considered to have lower nutritional 
value than their fresh commodities for a long time due to 
the loss of nutrients as vitamins. Concerning phenolic 
compounds, the results are contradicting in most studies. 
A few researchers have reported an increase in the 
phenolic content, while others observed a decrease. 
Indeed, Rohn et al. (2007) reported the thermal 
degradation of onion quercetinglucoside under roasting 
conditions (180°C), while Nikousaleh and Prakash (2016) 
noted that clove (Syzygium aromaticum Linn) exhibited a 
powerful antioxidant activity which increases under heat 
treatment and is positively correlated with antioxidant 
components.  
All previous studies (Bella et al., 2012; Atawodi et al., 
2014; Amadi et al., 2016) on the biological activities of 
each  individual spice extracts were performed with fresh 
or sun-dried materials (fruits, stems, barks). As the spices 
are heated during the cooking process, information on 
the antidiabetic activity of preheated spices is still 
unknown.  In the context of applied nutrition, if we want to 
use those plant extracts for therapeutic purposes, 
processing steps which can enhance the release of 
bioactive compounds and improve the variable biological 
activities should be applied. For domestic food 
consumption, obtaining plant extracts by infusion would 
be the fastest and most effective way, which also has the 
advantage of presenting the most important extraction 
yields that are positively correlated with the content of 
bioactive compounds following a very short extraction 
time (Khaoula  et al., 2018). Studying the synergic effects 
of the two plant species extracts used to handle many 
inflammatory diseases diabetes in domestic food 
consumption can cast light on their potentialities after the 
process that they undergo. 





treatment on the phytochemical characteristics of the two 
spices given above, define the phenolic profile of a 
beverage made with a mixture of the two spices and 
study its biological activity (hypoglycaemic) on diabetes 
complications. According to the heat treatment applied, a 
preliminary study was done in order to determine the 
optimum conditions of polyphenol extraction. Various 
formulations were assessed to choose the one with the 
best in vitro glucose trapping activity. Salvia officinalis 
infusion (Mediterranean spice with an anti-diabetic 
potential that is recognised worldwide), Glibenclamide  
and Acarbose were used as references to compare the 








T. tetraptera and A. citratum fruits are from Boanda 
(12°0'42.6960''E) and Ngato (15°2'50.8215''E) localities in the 
Central and Eastern regions in Cameroon, respectively. Each 
specimen was identified by Dr FongnzossieEvariste, botanist at the 
Higher Teacher's Training School for Technical Education (Douala 
University, Cameroon); voucher specimens (N°31610/NHC, 
N°37795/NHC respectively) were deposit in National Herbarium for 
further references. Salvia officinalis leaves were purchased, 




Chemicals and standards  
 
All chemicals and standards (for HPLC analysis) were of analytical 
grade, with at least 98% purity, and were used without further 
purification. Reference standards and the other chemicalsused 
were from Sigma-Aldrich (Merck Darmstadt, Germany). Acarbose 
and Glibenclamide  were pharmaceutical grade and obtained with a 
certificate of analysis.  
 
 
Heat treatment and preliminary studies 
 
Roasting temperature and time of the mixture (95/5: T. tetraptera/A. 
citratum) were chosen according to previous tests on polyphenol 
extraction optimisation. Initially, roasting temperature and time were 
selected by preliminary experiments on the basis of single factor 
multiple levels.Spices were heated at temperatures between 100 
and 240°C for 15 min to study the effect of roasting temperature; 
while roasting times between 5 and 30 min at 140°C (the roasting 
temperature with the highest total polyphenols content) were 
applied to study the effect of roasting time on total polyphenols 
contents. The optimal conditions were reached at a roasting 
temperature of 150°C, roasting time of 12.62 min and brewing time 
of 11.91 min. Dried spices were sliced into small equal 
pieces(around 1 cm2) and roasted using a home coffee roaster 
Machine(Vingloo, 1200 w; 110/220 V). After heat treatment, the 
spices were cooled at room temperature before crushing. The  
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powder was vacuum packed and stored at 4°C. 
 
 
Preparation of sample extracts and standards 
 
The plant aqueous extracts were obtained according to Yazdani et 
al. (2012)’s extraction procedure with slight modifications. The fruits 
were dried for 3 days at 40°C. They were sliced into small pieces 
before grinding using IKA Universal Mill M 20. The spices powder 
was sieved and particles with diameter less than 3.5 mm were used 
for aqueous extraction. Ground spices and hot water (100°C) were 
gently mixed at a ratio of 1:5. Extraction was performed for 11.91 
min (brewing time). The mixture was centrifuged (5000 rpm/10 min, 
4°C) and the supernatant was collected and filtered (Whatman 
No1). For phytochemical analysis, the supernatant was used and for 
the in vivo anti-diabetic activity of the beverage, the supernatant 
was freeze-dried before use.  
Concerning the HPLC analysis, the supernatant obtained 
previously was treated twice with an equal volume of n-hexane in a 
separating funnel. The aqueous phase was collected and freeze-
dried. For phytochemical compound identification, one gram of the 
dried aqueous sample was diluted into 5mL of de-ionised water and 
the solution wasdegassed in an ultrasonic bath (Fisher Scientific 
ultrasonic bath, Elma Germany) prior to use. It was filtered through 
a 0.45µm membrane filter (Millipore) directly into a 2ml HPLC vial. 
Stock solutions of standards were prepared in the HPLC mobile 
phase at a concentration range of 0.025-0.2 mg/ml and were 
handled as previously described. 
 
 
Phytochemical analysis and in vitro antidiabetic activity 
(Glucose adsorption capacity of spice formulations extracts) 
 
The total polyphenols content (TPP) was assessed using the Folin-
Ciocalteau colorimetric method, with slight modifications (Moukette 
et al., 2015); it was calculated from the Gallic Acid standard curve 
(0–1000μg/ml) and expressed as mg GAE/g dw (mg Gallic Acid 
Equivalent/g dry weight). The total flavonoids content (TFL) was 
also quantified according to Alara et al. (2017), with slight 
modifications from a Catechin standard curve (0-1000 μg/ml) and 
expressed as mg CE/g dw (mg Catechin Equivalent/g dry weight). 
Four formulations were made with T. tetrapteraand A. citratumin 
the following proportions: 95/5, 90/10, 85/15 and 80/10 (w/w). For 
the in vitro antidiabetic activity (Devi and Das, 2015), 1 ml of 
glucose solution (12.5, 25, 37.5 and 50%) was mixed with 1 mL of 
the beverage (5, 10, 15 and 20 mg/ml). The control consisted of 1 
ml of glucose and 1 mL of distilled water. The resulting mixture was 
centrifuged (4800 rpm/20min) and incubated (37°C for 1h). The 
glucose content was determined in the supernatant using the 
glucose oxidase peroxidase diagnostic kit (Chronolab, USA).  
 
 
High performance liquid chromatography (HPLC) analysis 
 
The spice extract phenolic compounds were obtained as described 
earlier and the phenolic compounds identification was performed 
according to Najafian et al. (2016) procedure, with modifications. 
The phenolic compounds were fractionated by an Agilent 1100 
series HPLC (Palo Alto, CA) system equipped with a photodiode 
array detector (HPLC-DAD) and a multiple wavelength detector, an 
online degasser, a cooler autosampler, a quatpump, a column 
heater and a PoroshellZorbax 6 XDB-C18 column (4.6 × 250 mm × 
5 μm diameter particles, Agilent) thermostated at 40°C.The eluates 
were detected at 210, 250, 280 and 320 nm. Gradient elution was 
performed to achieve maximum separation and sensitivity. Elution 
was performed by varying the proportion of acetonitrile solvent to 
0.1% formic acid in deionized water as follows: water containing 





acetonitrile containing 0.1% formic acid/water with 0.1% formic acid 
(20:80) at 16 min; acetonitrile containing 0.1% formic acid/water 
with 0.1% formic acid (25:75) at 19-22 min; acetonitrile containing 
0.1% formic acid/water with 0.1% formic acid (30:70) at 26 min; 
acetonitrile containing 0.1% formic acid/water with 0.1% formic acid 
(100:0) at 27-29 min and finally acetonitrile containing 0.1% formic 
acid/water with 0.1% formic acid (10:90) at 30-35; this was done for 
a total running time of 35 min and an  injection volume of 10 µl 
using an autosampler. 
For the method optimisation, several conditions, columns, 
solvents, times and mobile phases were used to obtain the 
optimum separation of each standard in the extracts. To check the 
selectivity, a diode array detector (DAD) was used to identify the 
standard and verify the peak purity during the analytical run of the 
extracts. The retention time of the standard was used to identify the 
analytical chromatographic profile comparison of the UV spectra 
was carried out. The linearity of the detector response for the 
prepared standards was assessed by means of linear regression 
regarding the amount of each standard and the area of the 
corresponding peak on the chromatogram. Method sensitivity was 
assessed by determining the limit of detection (LOD) and the limit of 
quantification (LOQ) for each compound. LOD and LOQ were 
calculated based on the standard deviation of the responses and 
the slope using three independent analytical curves. A standard 
additional method was utilised to assess recovery behaviour 
(accuracy). The addition of known amounts of organic acids, 
polyphenols to the spice samples tested for two concentrations 
levels were used and replicated three times. Average recovery was 
calculated by comparing mean values of replicates with theoretical 





Male Wistar albino rats (204-302g) were housed in standard 
environmental conditions at the animal house of Nutrition and 
Nutritional Biochemistry laboratory in Yaounde I University, 
Cameroon (T: 25 ± 6°C; RH: 55-65 % and 12h light/dark cycle), fed 
with a market standard food and water ad libitum. This study was 
conducted according to the "Guide for the Care and Use of 
Laboratory Animals, Eighth Edition" which is universally recognised 




Diabetes induction and diagnosis 
 
Diabetes was induced according to Akbarzadeh et al. (2007) 
method with slight modifications by the intraperitoneal 
administration of STZ (Sigma Aldrich Chemical 98% purity, USA). 
After STZ administration (2ml/kg at a dose of 55mg/kg), animals 
received a solution of glucose (20%) 2h after food. The diagnosis 
was carried out 24h after fasting by measuring glycaemia. Diabetes 
was diagnosed after recording glycaemia above or equal to 
200mg/dL (Chang et al., 2000). After diabetes was confirmed, the 




Acute anti-hyperglycaemic activity of the beverage (AEF) on 
diabetic rats 
 
The test was performed for a period of 4h, one week after the  
beginning of the experiment (Hussain et al., 2012). Twenty diabetic 
rats were fasted 12h before they were divided according to 
glycaemia (Table 1). Initial glycaemia was measured before the 
administration of AEF (250 mg/kg bw) and reference drugs. Starch 
solution was administered 30min later. Glycaemia was taken 30 






















NC Normal control 4 Diabetic Distilled water 
PC Positive control 4 Diabetic Starch Sol. (2g/kg bw) + Distilled  
water 
FOR Test Group 4 Diabetic Starch Sol. (2g/kg bw) + AEF  
(250 mg/kg bw) 
FOR-DAO Test Group 4 Diabetic Starch Sol. (2g/kg bw) + AEF  
(250 mg/kg bw) + Glibenclamide 
(3mg/kg bw 





ic activity  
NC Normal  control 4 Normoglycaemic Distilled water 
PC Positive control 4 Diabetic Distilled water 
FOR Test Group 4 Diabetic AEF (250 mg/kg bw) 
FOR-DAO Test Group 4 Diabetic AEF (250 mg/kg bw) + 
Glibenclamide (3mg/kg bw) 
DAO Reference drug 4 Diabetic Glibenclamide (3 mg/kg bw) 
SAU Reference spice 4 Diabetic AES (250 mg/kg bw) 
 




the starch solution by slight bleeding from the distal tip of the tail. 
 
 
Acute and subacute hypoglycaemic effects of AEF on diabetic 
rats 
 
The subacute hypoglycaemic effects of AEF were evaluated over a 
period of 14 days on a total of 20 diabetic rats and 4 
normoglycaemic rats following the experimental design described in 
Table 1. The body weights of the rats were recorded during the 
assay using a digital scale.The administration volume of each 
treatment was 5ml/kg. During acute tests, glycaemia was measured 
in the morning, during fasting, just prior to the administration of the 
different treatments, 30 min, 2h and 5h later. As part of the 
subacute tests, glycaemia was confirmed by fasting on days 3, 7, 
10 and 14 after the beginning of the test.  
The percentage of glycaemia reduction was calculated for the 
anti-hyperglycaemic and hypoglycaemic activities using the formula: 
 
Where G0 is the initial value of glycaemia and Gx is the measured 
blood glucose at a given time 
 
 
The preparation of hemolysates of erythrocytes and organ 
homogenates  
 
After testing, glycaemia was confirmed in rats fasted for 12h. The 
blood was left to stand for 4h at room temperature and then 
centrifuged (1500 rpm/10 min, 4°C). The collected plasma was 
stored at -20°C. Hemolysates (Menon et al., 2016) and organ 




Relevant biochemical assays 
 
The following biochemical parameters related to diabetes 
complications were measured: total cholesterol and serum 
triglycerides (the oxidase method using a commercial kit: Biolabo 
SA, Maizy, France); hepatic glycogen (Sullivan et al., 2014); liver, 
kidney and plasma transaminase (ALT and AST) activities 
(Schumann et al., 2002); total protein contents (Lowry et al., 1951); 
total homogenate antioxidant capacity by the Phosphomolybdenum 
method (Prietoet al., 1999); catalase and superoxide dismutase 
(SOD) activities (Nelson and Kiesow, 1972; Misraand Fridovich, 
1972 cited by Junli et al., 2009);  Hydroperoxide (Jiang et al., 
1992) and Malondialdehyde (Yagi, 1976) contents. 
 
 
Statistical analysis  
 
All of the measurements were performed in three replicates. 
Statistical analyses were performed using statistical packages for 
Social sciences (SPSS, version 21.0) and MINITAB (LLC, version 
19) software. The results were expressed as Mean ± SD; student’s 
t-test, one way ANOVA followed by the Tukey's posthoc 
comparison test were used to determine the values of p. Significant 
differences were noted when p<0.05. 
 
 
RESULTS AND DISCUSSION 
 
Effects of roasting on total polyphenols and total 
flavonoids contents 
 
The TPP and TFL of the different spices are recorded in 
Figure 1. For both species and the mixture, the heat  
treatment increased the amounts of TPP and TFL. 
However, changes were significant (p<0.05) for T. 
tetraptera and the mixture. It should also be noticed that 
the two spices contain significant amounts of polyphenols 
and flavonoids. Mixing A. citratum and T. tetraptera 
significantly (p˂0.05) improved the TPP and TFL 
contents. The percentage differences between TPP and 
TFL on raw and roasted T. tetraptera fruits were higher 
on average than those observed in A. citratum fruits, 







Figure 1. Total polyphenols and flavonoids contents of raw and roasted aqueous extracts of T. tetrapleura, A. citratum fruits and the 
formulation. Means with different superscripts (a, b) are significantly different (p˂0.05); GAE: Gallic acid equivalent; CE: Catechin 




characteristics at that temperature was the most 
important in the species. We can notice also that the 
release of phenolic compounds was more important in 
the formulation.The registered results can be explained 
by the degradation of complex phenolic tannins and also 
the enzymatic or non-enzymatic oxidation process leads 




In vitroglucose adsorption capacity 
 
The glucose adsorption capacities of the plant extracts 
are presented in Figure 2. The extracts are significantly 
(p<0.05) binding glucose at any concentration and the 
binding activity is proportional to the extract and glucose 
concentrations and inversely proportional to the fraction 
of A. citratumin the formulation. Formulation 95/5 (T. 
tetraptera/A. citratum) has a significantly greater activity 
for a given glucose and extracts concentration and was 
therefore chosen for the in vivo test.  
The result obtained can be attributed to their dietary 
fibre contents because fibres have the ability to adsorb 
glucose (Ahmed et al., 2011). Indeed, T. tetraptera 
contains raw fibre that can exceed 40% (Mboto et al., 
2013). One of the mechanisms by which fibres help to 
reduce glucose is by binding free glucose, inducing the 
drop in glucose concentration (Ahmed et al., 2011). This 
reduction can also be attributed to their physicochemical 
composition (alkaloids, flavonoids, phenols, tannins, 
triterpenes, anthraquinones, saponins, peptides, 
glycopeptides, inorganic ions, guanidines, steroids), as 
reported by Irondi et al. (2016). Most of those compounds 
are involved in the bioavailability of glucose (Govindappa, 
2015) by various in vivo (blocking K+ channels of 
pancreatic β-cells by the stimulation of AMPc; inhibition of 
kidney glucose reabsorption; stimulation of insulin 
secretion by the β-cells of the islets and/or inhibition of 
insulin degradation process; regeneration of pancreatic β-
cells; stimulation of gluconeogenesis and glycolysis in 
liver; prevention of pathological conversion of starch in 
glucose; and inhibition of β-galactosidase and α-
glucosidase) and in vitro (adsorption) pathways according 
to Bhutkar et al. (2017). The binding capacity reduces 
with an increase in the A. citratum portion in the 
formulation, as the total polyphenol composition of T. 
tetraptera extracts is more than 5 times greater than that 
of A. citratum. 
 
 
Identification and quantification of phenolic and 
heterocyclic compounds on F (95/5) extracts 
 
The analysis showed the presence of many phenolic and 
aromatic compounds with potential biological activities in 
the beverage. The chromatographic parameters of the 













































































































total, 12 phenolic acids, ten flavonoids, one 
alkaloid (Theobromine), and one pyranone (Kojic 
acid) were identified and quantified (Table 3). All 
tested substances are well known antioxidants. 
Among the phenolic compounds: Flavone (1666.2 
µg/g dw), Naringin (349.7 µg/g dw), Protocatechic 
acid (347.8 µg/g dw), chlorogenic acid (343.9 µg/g 
dw) and p-Coumaric acid (268.9 µg/g dw) showed 
the highest concentrations for both detection 
wavelengths (Figure 3). However, Luteolin, 
Mangeferin, and Trans-OH Cinnamic acid were 
determined at trace levels (Table 3).  
All of these compounds have already been 
detected in aqueous, methanol and ethanol 
extracts of T. tetraptera (Sokamte et al., 2019; 
Odubanjo et al., 2018; Amadi et al., 2016), but the 
amounts recorded are lower than the quantities 
already published for aqueous extracts. Among 
the phenolic and aromatic compounds identified 
and quantified for the plant species, the presence 
of Kojic acid, Cyanidin chloride, Myricetin, 
Salicylic acid, Mangeferin, Naringin and 
Protocatechic acid has not yet been reported for 
the two plant species. Experimentally, the 
relatively high polyphenols content (flavonoids) 
contributes to the control of oxidative stress 
(Ghorbani and Esmaeilizadeh, 2017). Several 
phenolic and derivative compounds identified by 
HPLC explain the observed AEF activities, and 
Glibenclamide reinforces the antioxidant system 
by limiting the metabolic damage caused by 
diabetes (Kusano and Ferrari, 2008). Indeed, 
Catechin, Epicatechin, Gallocatechin, 
Epigallocatechin and their derivatives positively 
affect inflammatory diseases, such as Type 2 





Table 2. Regression curves, retention times, linearity, limit of quantification, limit of detection and percentage recovery of polyphenols and derivatives obtained using the proposed 
methodology. 
 




(min) λmax(nm) Standard curve r





Gallic acid Phenolic acid 0.025–0.20 2.451 ± 0.05 210, 250 y = 192.66 x – 0.073 0.99 0.672 1.425 97.13 ± 1.32 
(-)Gallocatechin Flavanol 0.035–0.20 3.460 ± 0.00 210, 250 y = 281.27 x + 0.089 1 0.369 0.783 94.07 ± 2.16 
Protocatechic acid Phenolic acid 0.025–0.20 4.282 ± 0.07 210, 250 y = 334.56 x + 0.018 1 0.108 0.229 98.25 ± 0.27 
Chlorogenic acid Phenolic acid 0.025–0.20 6.517 ± 0.01 280, 320 y = 21.604 x + 0.063 0.99 0.127 0.270 97.32 ± 0.97 
(+-) Catechin Flavanol 0.05–0.20 6.834 ± 0.08 210 y = 309.32 x + 0.016 0.99 0.008 0.017 99.00 ± 0.15 
Cafeic acid Phenolic acid 0.025–0.20 8.537 ± 0.00 210, 320 y = 58.02 x + 0.008 0.98 1.565 3.320 96.49 ± 1.77 
Mangeferin Xanthone 0.05–0.20 9.052 ± 0.00 250 y = 55.71 x + 0.033 0.96 0.048 0.102 98.24 ± 0.22 
3-OH Benzoic acid Phenolic acid 0.025–0.20 9.444 ± 0.05 210 y = 364.94 x – 0.082 0.99 0.011 0.025 94.75 ± 2.22 
Epigallocatechingallate Flavanol 0.025–0.20 10.33 ± 0.02 210 y = 59.86 x – 0.076 0.98 0.062 0.133 96.73 ± 1.47 
p-Coumaric acid  Phenolic acid 0.025–0.20 13.157 ± 0.03 210, 320 y = 65.07 x + 0.038 1 0.080 0.170 99.03 ± 1.00 
Cyanidin chloride Anthocyanidin 0.05–0.20 13.925 ± 0.02 210, 280 y = 55.71 x + 0.033 0.96 0.048 0.102 98.71 ± 2.33 
Syringic acid Phenolic acid 0.025–0.20 14.900 ± 0.01 210, 280 y = 50.37x + 0.007 0.99 1.686 3.578 99.33 ± 1.74 
Ferulic acid Phenolic acid 0.025–0.20 15.223 ± 0.05 320 y = 49.00 x – 0.012 1 0.360 0.764 95.71 ± 3.14 
Rutin Flavonol 0.05–0.25 15.900 ± 0.01 250, 320 y = 13.24 x + 0.020 0.98 0.519 1.102 100.16 ± 2.38 
Trans-OH-cinnamic acid Phenolic acid 0.025–0.20 16.533 ± 0.04 210, 280 y = 68.59 x + 0.046 0.99 1.388 2.944 95.24 ± 0.44 
Benzoic acid Phenolic acid 0.025–0.20 18.232 ± 0.03 210 y = 29.87 x – 0.021 0.98 1.488 3.156 94.73 ± 1.11 
Naringin Flavanone 0.05–0.25 20.139 ± 0.00 210, 280 y = 253.83 x + 0.013 0.99 0.206 0.437 96.75 ± 1.78 
Salicylic acid Phenolic acid 0.025–0.20 20.439 ± 0.02 210 y = 364.831 x + 0.045 1 0.155 0.330 99.49 ± 0.53 
Myricetin Flavonol 0.05–0.25 21.734 ± 0.11 210, 250 y = 5.10 x + 0.06 0.98 2.638 5.597 95.53 ± 2.47 
Luteolin Flavone  0.025–0.20 27.598 ± 0.00 210, 280 y = 221.352x + 0.083 0.99 0.013 0.028 100.02 ± 1.16 
Cinnamic acid Phenolic acid 0.025–0.20 27.706 ± 0.12 280 y = 257.90 x + 0.084 0.98 0.530 1.125 96.14 ± 2.14 
Flavone Flavone  0.025–0.20 29.663 ± 0.03 250, 280 y = 40.28 x + 0.139 0.98 2.339 4.962 97.49 ± 1.68 
Transchalcone Chalcone 0.025–0.20 29.918 ± 0.01 250,280 y = 43.59 x + 0.007 0.99 0.557 1.183 100.15 ± 2.97 
Kojic acid Pyrone 0.025–0.20 2.066 ± 0.02 210, 250 y = 195.21 x + 0.061 0.98 0.121 0.257 99.49 ± 1.02 




decreasing the expression of IL-6 and MCP-1 and 
increasing the production of the anti-inflammatory 
compounds, adipokine and adiponectin (Aryaeian 
et al., 2017). Rutin is involved in the activation of 
liver enzymes associatedwith gluconeogenesis 
and lipid metabolic processes and also decreases 
the levels of fasting blood glucose, creatinine, 
blood urea nitrogen, urine protein and the intensity 
of oxidative stress significantly. Rutin has also 
been reported to significantly improve body 
weight, reduce HbA1c and pro-inflammatory 
cytokines (IL-6 and TNF-alpha), and restore the 
depleted liver antioxidant status and serum lipid 
profile in STZ-induced diabetic rats (Vinayagam 
and Xu, 2015). Cyanidin chloride has been 
demonstrated to inhibit intestinal α-glucosidase 
and pancreatic α-amylase, which is one of the 
therapeutic approaches for treatment of T2D 
according to the same authors. Naringin is 
effective at protecting against the development of 





Table 3. Phenolic and aromatic compounds contents (mg/g dw) of aqueous extract of pre-heated F (95/5) at the maximum absorption 
wavelength ( λmax) 
 
Phenolic acids  Amounts Flavonoids Amounts Other aromatic compounds Amounts 
Protocatechic acid 3.47 ± 1.81 Flavone 1.666 ± 0.31 Kojic acid 4.19 ± 0.21 
Chlorogenic acid 3.439 ± 0.71 Naringin 0.349 ± 0.11 Theobromine - 
p-Coumaric acid 2.689 ± 0.56 Epigallocatechingallate 0.214 ± 0.09   
3-OH Benzoic acid 0.233 ± 0.08 (+-) Catechin 0.806 ± 0.07   
Benzoic acid 0.1893± 0.08 Cyanidin chloride 0.756 ± 0.17   
Salicylic acid 0.170 ± 0.06 Myricetin 0.512 ± 0.24   
Syringic acid 0.893 ± 0.10 Rutin 0.407 ± 0.10   
Ferulic acid 0.735 ± 0.11 (-)Gallocatechin Traces   
Cinnamic acid 0.641 ± 0.18 Luteolin Traces   
Trans-OH-cinnamic Traces Transchalcone -   
Gallic acid Traces Mangeferin -   






Figure 3. Representative high performance liquid chromatography profiles of pre-heated F (95/5) at various 
wavelengths (a: 210 nm; b: 250 nm; c: 280 nm; d: 320 nm). 1: Kojic acid; 2: Gallic acid; 3: Theobromine; 4: (-) 
Gallocatechin; 5: Ptotocatechic; 6: Chlorogenic acid; 7: (+-) Catechin; 8: Cafeic acid; 9: Mangeferin; 10: 3-OH Benzoic 
acid; 11: Epigallocatechinegallate; 12: p-Coumaric; 13: Cyanidin chloride; 14: Syringic acid, 15: Ferulic acid; 16: Rutin; 
17: Trans-OH cinnamic acid; 18: Benzoic acid; 19: Naringin; 20: Salycilic acid; 21: Myricetin; 22: Luteolin; 23: Cinnamic 
acid; 24:Flavone; 25: Transchalcone 
 
(a) (b)  









                                                             Time 
Groups  (n = 4) 
Blood glucose concentration (mg/dL) 
0min 1h 2h 3h 4h 







411.75 ± 15.28 409.25±21.34 408.25±18.40 399.75±18.57 396.00±10.51 
(0.00±0.00%) (-0.62±2.70%) b (-0.84±2.82%) a (-2.91±2.72 %) ab (-3.78±2.15%) a 
PC: Starch Sol. (2g/kg bw) + Distilled 
water 
514.50±20.02 585.50±17.69 565.50±42.18 535.25±57.59 520.50±50.48 
(0.00±0.00%) (13.86±3.29%) ab (9.87±6.07%) a (3.91±8.64%) a (1.13±8.40%)a 
FOR:  Starch Sol. (2g/kg bw) + AEF 
(250 mg/kg bw) 
420.75±89.86 517.75±42.75 451.75±30.31 394.25±41.91 324.25±59.82 
(0.00±0.00 %) (25.91±18.85%) a (10.02±16.67%) a (-4.26±14.34%) ab (-22.42±6.09%) b 
FOR-DAO: Starch Sol. (2g/kg bw) + 
AEF (250 mg/kg bw) + Glibencla- 
mide (3mg/kg bw 
490.2 ±49.50 535.50±48.43 497.75±54.65 416.25±31.71 359.25±23.21 
(0.00±0.00 %) (9.33±2.00%) b (1.60±4.87%) a (-14.88±3.71%) ab (-26.26±7.36%) bc 
ACARB: Starch Sol. (2g/kg bw) + 
Acarbose (2mg/kg bw) 
472.75±21.28 525.00±24.67 445.00±27.26 372.50±45.09 314.00±25.39 
(0.00±0.00 %) (11.05±1.86 %) b (-5.86±3.83%) a (-21.06±10.33%) b (-33.53±5.26%) c 
 
The values in brackets represent the blood glucose percentage changes compared to the initial glycemia; The average percentage changes followed by different letters (a, b, c) in the same column 




of hepatic genes involved in lipid metabolism and 
gluconeogenesis via their up-regulation 
(Vinayagam and Xu, 2015). Concerning phenolic 
acids (Caffeic, Chlorogenic, Protocatechuic, p-
Coumaric, Cinnamic, Gallic, Syringic, Ferulic, 
Salicylic) and Kojic acid, an anti-diabetic activity 
has been reported (Vinayagam and Xu, 2015; 
Amadi et al., 2016; Saeedi et al., 2019).  
Chlorogenic acid has a glucose absorption 
inhibitory effect and modulates oxidative stress, 
while p-Coumaric acid has a glucose lowering 
effect in STZ-induced diabetic rats (Shairibha et 
al., 2014) and modulates glucose and lipid 
metabolism via 5’-adenosine monophosphate-
activated protein (AMPK) activation in L6 skeletal 
muscle cells (Vinayagam and Xu, 2015). It was 
also found to be highly effective in managing the 
complications associated with diabetes mellitus, 
such as insulin maintenance, protein metabolism 
and carbohydrate-metabolising enzymes. Ferulic 
acid is reported to decrease blood glucose levels, 
glucose-6-phosphatase and phosphoenol 
pyruvate carboxykinase activities and to increase 
glycogen and insulin by reducing oxidative stress 
and the inflammation pathway. Syringic acid has 
the potential to secrete insulin from existing islet 
β-cells alloxan-induced diabetic rats. Treatment 
with Gallic acid on db/db mice and fructose-
administered rats facilitated glucose homeostasis, 
improved insulin sensitivity, reduced obesity,  
reduced elevated blood pressure and decreased 
cholesterol levels, as well as inducing 
adipogenesis in 3T3-L1 adipocytes (Variya et al., 
2019). A strong body of evidence supports the 
biological activity in vitro of Protocatechuic acid as 
an antioxidant and insulin-mimetic molecule in 
different biological models (Ormazabal et al., 
2018).  
For the method optimisation, the validation 
parameters (linearity, accuracy, sensibility) are 
presented on Table 2. The correlation coefficients 
of all the calibration curves were greater than 
0.98. The results obtained show percentages of 
recovery between 94.07 and 100.16%. The 
recovery values are considered acceptable 
(González-González et al., 2019) according to 
Commission Decision (2002/657/EC). LOD values 
were  calculated between 0.008 and 2.638 µg/ml 




AEF Anti-hyperglycaemic activity 
 
There was an increase in glycaemia (Table 4) 
following the administration of starch in all groups 
except the Normal Control group and the 
glycaemic peaks were observed after 1h. AEF 
showed an anti-hyperglycaemic effect after 2h 
and the drop of the glycaemia is more pronounced 
after 4h compared to the Positive Control group. 
The effect of AEFis statistically identical to that of 
AEF-Glibenclamide after 4h while the influence of 
AEF-Glibenclamide remains identical to that of 
Acarbose. The above results on the in vitro 





Table 5 . Acute and subacute effects of oral administration of AEF on rats blood glucose (mg/dL) in the different groups 
 
 Blood glucose concentration (mg/dL) 
                                  Time 





74.00±3.46 72.50±2.38 72.50±2.38 73.00±2.16 73.25±1.71 73.25±1.71 73.00±0.82 73.00 ± 2.58 
(0.00±0.00%) (-1.95±0.81%)b (-1.95±0.87%)c (-1.27±2.99%)c (-0.83±5.58%)d (-0.83±5.28 %)c (-1.18±4.14%)d (-1.22±4.98%)c 
PC:Distilled 
water 
Diabetic rats  
 
599.81±0.00 599.42±0.01 599.40±0.001 599.01±0.0031 513.40±33.36 511.60±18.51 505.00±15.81 498.00±29.50 
(0.00±0.00%) (-0.07±0.00%)b (-0.07±0.00%)c (-0.13±0.00%) c (-14.41±3.1 %)c (-14.71±3.08%)b (-15.81±2.63%)c (-16.97±4.91%)b 
FOR : AEF 
(250 mg/kg bw) 
600.003±0.00 572.20±7.06 560.20±48.19 489.40±67.72 380.40±83.12 325.00±10.31 333.00±17.15 233.40±19.25 
(0.00±0.00%) (-4.63±2.06%)a (-6.63±3.03%)b (-18.43±11.3%)b (-43.27±13.9 %)b (-45.83±17.3%)a (-44.50±28.6%)b (-61.10±32.1%)a 
FOR-DAO: 
AEF (250 
mg/kg bw) + 
Glibenclamide 
(3mg/kg bw)  
599.65±0.14 600.00±0.002 577.10±0.32 399.75±49.45 174.50±13.14 190.25±12.76 166.25±86.38 128.25±18.06 
(0.00±0.00%) (0.06±0.01%)b (-3.76±1.07%)c (-33.32±8.24%)a (-70.86±21.9%)a (-68.23±21.3%)a (-72.23±14.9%)a (-78.57±3.01%)a 
DAO: 
Glibenclamide  
(3 mg/kg bw) 
599.77±0.03 555.75±6.55 481.75±16.25 468.50±27.14 315.00±27.25 243.00±42.03 205.50±25.52 214.75±23.12 
(0.00±0.00%) (-7.34±1.09%)a (-19.68±2.7%)a (-21.89±4.52%) b (-47.48±4.54%)b (-59.48±7.00%)a (-65.74±4.3%)ab (-64.19±3.85%)a 
SAU: AES (250 
mg/kg bw) 
598.94±00.02 568.50±23.90 512.75±37.94 497.15±34.59 360.00±10.81 240.25±35.92 176.75±6.07 153.75±22.91 
(0.00±0.00%) (-5.08±3.42%)a (-14.39±4.1%)a (-17.00±3.17%) b (-39.9±27.01%)b (-59.89±8.73%)a (-70.49±2.70%)a (-74.33±6.52%)a 
 
The values in brackets represent the blood glucose percentage changes compared to the initial glycaemia.  
Average varying percentages followed by different letters (a, b) on the same column are significantly different at 5% level. 




verified by those obtained via the in vivo study of 
the hypoglycaemic activity of AEF in diabetic rats. 
Indeed, AEF demonstrated a hypoglycaemic 
action identical to that of AEF- Glibenclamide, 
which was previously reported (Atawodi et al., 
2014). In that report, the diabetic groups treated 
with either the methanolic extract of T. 
tetraptera leaf or Glibenclamide showed 
significant percentage change (p<0.05) in the 
fasting blood sugar level (30.15 and 47.56%, 
respectively) compared to the diabetic (0.59%) 
and normal controls (2.30%) between Day 0 and 
Day 7. Similarities have been noted with 
Trigonellafoenum-graecum (Leguminosae) seed 
powder commonly known as Shanbalileh, a 
natural Persian herb. The seed powder 
significantly decreases the hyperglycaemic peak 
and/or the area under the glucose tolerance curve 
according to Alarcon-Aguilara et al. (1998); Cited 
by Shojaee et al. (2015). 
 
 
AEF acute and subacute hypoglycaemic 
activities  
 
During the acute test, no change in glycaemia 
was observed in the Positive control group (Table 
5); however, AEF decreased blood glucose from 
the 30th min until the 5th h. AEF was more effective 
than AEF-Glibenclamide during the first 2h and 
less effective after 5h. In fact, glycaemia 
reductions followed this order: AEF-
Glibenclamide>Glibenclamide ≥ AEF ≥ AES > NC 
≥ PC after 5h. AEF had a similar performance with 
that of Glibenclamide and AES. 
Concerning subacute test, AEF reduces 
glycaemia and the reduction is increased from the 
3rd day to the end. This decrease is similar to that 
observed in the groups receiving AES, AEF-
Glibenclamide, Glibenclamide and below that of 
the PC group. However, the efficiency of AEF is 











Glibenclamide for the first three days. AEF increased the 
Glibenclamide efficiency with a significant blood glucose 
reduction. The hypoglycaemic tests confirm that the 
action of Glibenclamide is improved by the addition of 
AEF in the short and long term. However, the action of 
AEF is identical in the long term to that of AES whose 
hypoglycaemic properties have already been established 
(Hamidpour et al., 2014). Concerning another medicinal 
plant, Karami et al. (2016) report the therapeutic effect of 
hydro-alcoholic and aqueous extrcat (200mg/kg bw) of 
berberis vulgaris fruits on diabetic rats. The results reveal 
the significant reduction of blood glucose level after 30 
days of trial. The presence of Berberine (an alkaloid with 
antidiabetic effects) in this plant extract can easily explain 
the results noted. Indeed, according to the authors, 
Berberine can act like metformin in reducing serum 
glucose level by aldolase reductase inhibition, glycolysis 
induction, and prevention of insulin resistance through 
enhancing of insulin receptor expression. The 
mechanisms by which the synergic effect of A. citratum 
and T. tetraptera aqueous extracts lower the blood  
glucose levels are still unknown, but we think that it is in 
relation with their phytochemical content. However, 
according to Raju et al. (2001) cited by Shojaee et al. 
(2015), the role of phytochemicals on insulin secretion 
modulation, simulation of insulin action can be 
considered as the resulting therapeutic action. 
 
 
Effects of AEF on body weight (bw) 
 
There is a significant difference between the percentage 
variations of body weights within the groups for each time 
interval; however at this interval, the normoglycemic 
group possesses the positive and the highest 
percentages (Figure 4). After two weeks of AEF 
administration, the percentage variations of groups FOR, 
FOR+DAO, DAO body weights are not significantly 
different while the diabetic group receiving AES recorded 
the best bodyweight improvement. The results obtained 
are similar to those published bv Shojaee et al. (2015) 
who tested the effects of Galega officinalis and 
Trigobnellafoenum-graecum powder on diabetic mice. 
After 4 and 30 days of powder administration there was a 
significant decrease of body weights on diabetic mice 
whatever the dose administered. Different results were 
obtained by Hafezi et al. (2015) using Satureja 
Knuzestanica Jamzad extract on diabetic rats. The 
authors reported that both doses (100 and 300 mg/kg) 
could increase the body weight of male rat significantly 
(p < 0.05); and in positive control and excipient groups, 
these decreases were not significant (p > 0.05). Weight is 
a good indicator of health and efficiency of metabolic 
homeostasis, according to Jangir and Jain (2017). The 
results showed that despite a similar food disponibility in 
the six groups of animals, and consequently the same 
energy proportion, the diabetic rats experienced a 
significant decrease in body weight (bw).Omanri et al. 
(2011) demonstrated a loss of bw in diabetic Wistar rats 
given 45 mg / kg of STZ. The injection of STZ causes the 
onset of the diabetic syndrome characterized by 
polyphagia, polyuria, polydipsia and glycosuria, a fall in 
the bw coupled with a metabolic disorder affecting blood 
sugar, triglyceridemia and cholesterolemia. The weight 
reducing effect of our beverage can be also explained by 
the loss of body fats, according to Palit et al. (1999) cited 
by Shojaee et al. (2015). 
 
 
Effects of AEF on the carbohydrate metabolism  
 
The lowest glycogen levels were recorded in the Positive  
           
              































Table 6. Effects of the oral administration of AEF on rats livers glycogen concentration and on livers and kidneys transaminases activities  
 
 
                                                                       
                                                                             
                                                                              Organs                                                                                                                                                                                                                                     
Groups (n = 4) 
ALT (IU/mL) AST (IU/mL) Glycogen concentration (g/L)  
Liver kidney Liver kidney Liver  
 NC: Distilled water  Normoglycaemic 
rats 
100.68 ± 4.15 ab  57.95 ± 2.07 ab  44.31 ± 2.41 a 53.29 ± 1.66 a 6.78±0.46 a 
 PC: Distilled water  
 
Diabetic rats 
104.81 ± 2.47 a 60.68 ± 2.54 a 47.13 ± 1.65 a 53.13 ± 1.53 a 5.64±0.30 b 
FOR : AEF(250mg/kg bw) 101.36 ± 3.89 ab  56.76 ± 2.57 ab 46.18 ± 0.95 a 50.59 ± 3.76 ab 7.45±0.13 a 
FOR-DAO:  AEF (250mg/kg bw) + 
Glibenclamide (3mg/kg bw) 
98.75 ± 2.86 ab 62.38 ± 3.96 a 47.32 ± 1.25 a 45.22 ± 3.53 bc 6.67±0.65 a 
DAO : Glibenclamide (3mg/kg bw)  99.68 ± 4.52ab 56.50 ± 3.68 ab 45.79 ± 0.70 a 42.55 ± 4.57 cd 6.57±0.07 a 
SAU: AES (250mg/kg bw) 95.27 ± 4.13b 52.54 ± 3.88 b 44.59 ± 3.10 a 37.40 ± 5.06 d 6.89±0.43 a 
 
Means graded by different letters (a, b, c, d) per column are significantly different at 5% level.  




control group compared to Normal control (Table 
6). The treatments led to an increase in liver 
glycogen and no significant difference was 
observed between between the diabetic rats 
groups. However, AEF records the most important 
glucose storage (7.45g/L). This observation was 
also made for other anti-diabetic plants. Couturier 
et al. (2011) noticed it in diabetic rats treated with 
cinnamon extracts (Cinnamomum verum). The 
synergistic effects of AEF (inhibition of α-amylase 
and α-glucosidase) and Glibenclamide 
(stimulating insulin secretion by the pancreatic 
resistant β-cells) on glucose metabolism explain 
these observations. Polyphenols contained in 
plant extracts were described as inhibitors of the 
activity of these enzymes, including flavonoids, 
tannins and terpenoids (Mai et al., 2007). It is 
believed that the result is related to the chemical 
composition of AEF [presence of (-)Gallocatechin, 
(+-)Catechin, Epigallocatechin, Rutin, Flavone, 
Transchalcone, Luteolin, Myricetin, Naringin, and 
Cyanidin chloride], and the reverse effect of 
Glibenclamide 
 on glycogen metabolism.  
Concerning the liver and kidney transaminases 
(ALT, AST) activities, AEF allowed as well as 
Glibenclamide, and AEF-Glibenclamide the 
inhibition of gluconeogenesis by reducing and/or 
keeping constant the expression of these 
transaminases in all organs (Table 6). It is 
reported that their activity is proportional to the 
degree of liver damage and their increase in the 
bloodstream (Visweswara et al., 2013). The levels 
observed in both diabetic rat groups are due to 
the alleviation of damage caused by STZ. In other 
words, AEF, Glibenclamide, AEF-Glibenclamide 
and AES inhibit gluconeogenesis by reducing the 
expression of these transaminases. However, this 
inhibition is higher in both organs using AES and 
the effect of AEF-Glibenclamide is more effective 
than that of AEF alone. The results obtained with 
AEF are similar to those already mentioned 
(Atawodi et al., 2014; Kuate et al., 2015) and 
demonstrate that AEF reduces the adverse effects 
of diabetes, causing significant reduction of blood 
glucose, the expression of kidney, liver 
transaminases and enhancing the stimulation of 
glycogen synthesis.  
 
 
AEF effects on the antioxidant system  
 
No significant difference was noted between PC 
and NC goups in all target organs (Table 7) and 
plasma was shown to contain the highest TAC 
(test groups). AEF, AEF-Glibenclamide and 
Glibenclamide increased the TAC of all tissue 
homogenates and plasma compared to the 
Positive control group. AEF is more efficient than 
AEF-Glibenclamide and single Glibenclamide in 
the plasma (17.95±0.03mg AAE/ml). There is no 
significant difference between the effect of AEF 
and AEF-Glibenclamide in the liver and kidneys.   






Table 7. Effects of the oral administration of EAF on the antioxidant system (Total antioxidant capacity, superoxide dismutase or SOD and catalase activities) in rat tissue homogenates and hemolysate 
 
 
SOD (U/mg protein) Catalase (µM H2O2 cons/min/mg protein) 
                                                      Organs  
Groups (n = 4) Liver Pancreas Hemolysate kidney Liver Pancreas Hemolysate kidney 
NC: Distilled water Normoglycae-mic rats 94.64±3.64
 b 147.92±2.80 b 146.01±0.00c 66.05±2.17 b 52.52±3.00 a 263.70±22.93 b 57.25±10.12 a 28.90±6.70 c 
PC: Distilled water 
Diabetic rats 
88.47±3.21 b 122.12±6.90 c 76.85±4.90e 66.83±1.88 b 39.94±7.51b 245.16±10.07 b 57.00±15.74 a 26.87±4.39 c 
FOR: AEF(250 mg/kg bw) 89.06±2.62 b 130.85±4.36 c 176.85±5.90b 182.75±0.00a 27.89±4.90 c 197.61±11.36 c 50.51±5.77 a 27.00±3.60 c 
FOR-DAO: AEF (250 
mg/kg bw) + 
Glibenclamide (3mg/kg 
bw)  
90.00±3.05 b 180.76±5.93 a 66.31±2.55 e 66.86±2.12b 30.63±3.63 bc 309.02±5.91 a 22.98±4.37 b 41.36±6.26b 
DAO: Glibenclamide 
(3mg/kg bw) 93.94±2.97
 b 101.06±8.60 d 90.34±4.48d 68.90±2.65b 32.74±3.21 bc 149.87±7.97d 19.79±1.81 b 34.23±4.06 bc 




Table 7: (continued) 
 
 TAC 
 (mg AAE /mL)  
                                                                    Organs 
Groups (n = 4) 
Liver Pancreas Plasma kidney 
NC: Distilled water Normoglycaemic  
rats 
1.70±0.12 b 0.61±0.18 c 0.55±0.15 e 1.78±0.04 c 
PC: Distilled water 
 
Diabetic rats 
1.67±0.04 b 0.54±0.19 c 0.03±0.07 e 1.51±0.00 c 
FOR: AEF (250 mg/kg bw) 3.78±0.11 a 2.62±0.02 b 17.95±0.03 a 5.21±0.26 ab 
FOR-DAO: AEF (250 mg/kg bw) – 
Glibenclamide (3mg/kg bw) 
4.88±0.23 a 3.17±0.17 b 12.21±0.26 b 5.71±0.30 a 
DAO: Glibenclamide (3mg/kg bw) 4.24±0.13 a 4.29±0.03 a 10.44±0.01 c 4.70±0.29 b 
SAU: AES (250 mg/kg bw) 1.94±0.32 b 0.63±0.10 c 1.59±0.04 d 1.67±0.17 c 
 
The means graded with different letters (a, b, c, d) in the same column are significantly different at 5% level.  





















NC: Distilled water  Normoglycae-
mic rats 
61.12±2.10 ab 21.19±2.18 c 65.11±2.62 a 50.96±2.16 a 
PC: Distilled water 
 
Diabetic rats 
59.80±2.61 b 38.60±1.47 a 65.68±2.50 a 51.23±2.16 a 
FOR: AEF (250mg/kg bw) 49.70±5.36 c 28.58±2.48 b 62.00±2.80 a 49.40±1.64 a 
FOR-DAO: AEF (250mg/kg bw) + 
Glibenclamide (3mg/kg bw) 
67.60±7.30 a 19.74±3.58 c 68.35±5.11 a 51.53±1.92 a 
DAO: Glibenclamide (3mg/kg bw) 63.62±3.53 ab 28.62±2.44 b 67.27±2.13 a 39.71±4.86 b 
SAU: AES (250mg/kg bw) 62.19±3.00 ab 21.83±1.48 c 64.90±2.53 a 48.81±2.84 a 
 
The means assigned with different letters (a, b, c) in the same column are significantly different at 5% level;  




Concerning the  effect  of AEF on the enzymatic 
antioxidant system, the Positive control group has the 
lowest SOD and Catalase activities in the pancreas and 
hemolysates compared to Normal control (Table 7). AEF 
induces the highest activities in the hemolysates and 
kidneys compared to the PC group. The formulation 
enhances the efficacy of Glibenclamide by increasing the 
SOD activity in pancreas homogenates. AEF is more 
effective than Glibenclamide in the pancreas, 
hemolysates and kidneys. AES is more active in the liver 
and hemolysates than AEF. About catalase activity, there 
is no difference between the controls on the target organs 
(except for the liver). There is an increase of this activity 
in the pancreas and hemolysates for groups receiving 
Glibenclamide and AEF-Glibenclamide. AES is more 
efficient in the liver, kidney and pancreas compared to 
AEF. 
The antioxidant markers (enzymatic and non-
enzymatic) studied is used by the body to control ROS 
production. The results obtained are identical to previous 
studies where scientists reported an increase in TAC in 
diabetic rat (STZ) tissues receiving the phenethyl ester of 
caffeic acid (Okutan et al., 2005) and an improvement in 
SOD and catalase activities in diabetic rats following 
treatment with rosmarinic acid (Govindaraj and 
Subramanian, 2015). The increase in SOD and catalase 
activities is similar to observations made for T. tetraptera 
extracts (Bella et al., 2012; Atawodi et al., 2014) and S. 
officinalis extracts (Kolac et al., 2017).  
 
 
Influence of AEF on lipid profile 
 
There is no change between the controls concerning rat 
cholesterolaemia while triglyceridaemia was significantly 
higher in the Positive control group compared to Normal 
control group (Table 8). AEF lowers cholesterolaemia by 
about 17% compared to the positive control group, while 
the other treatments had no significant effect on 
cholesterolaemia. Triglycerides content was significantly 
lower in the group receiving AEF compared to controls. 
However, the effect of AEF is identical to the 
Glibenclamide activity while AEF-Glibenclamide  and 
AES are more effective. To the best of our knowledge, 
insulin deficiency is strongly correlated with 
hyperglycaemia, hypercholesterolemia and 
hyperlipidaemia (Govindappa, 2015). Unlike this author, 
we note that AEF has a cholesterol and triglyceride 
lowering effect in diabetic rats. The results match those of 
previous discoveries where T. tetraptera aqueous and 
hydroethanolic extracts, respectively were used (Bella et 
al., 2012; Atawodi et al., 2014). The groups receiving 
Glibenclamide or AEF-Glibenclamide recorded a slight 
increase in cholesterol amounts, but this was not 
significant compared to controls. This result is identical to 
the report of the previous authors, demonstrating that 
metformin has no significant effect on the cholesterol 
content of skeletal muscle and the liver in diabetic rats. 
The results obtained with EAS are identical to a report 
where the levels remained unchanged, as reported for 




Effect of AEF on hydroperoxides and 
malondialdehyde (lipid peroxidation markers) content 
 
The various treatments lower ROOH levels compared to 
the Positive control group in the plasma (Table 9). 
Groups receiving AEF and AEF-Glibenclamide have 
identical ROOH contents with the NC group for all target 
organs. However, AES significantly lowers ROOH 
content in the liver. With regard to MDA levels, the 
Positive control group presents significantly (p<0.05) 
higher amounts in the kidneys compared to Negative 
Control group and no difference was observed in the 
other target organs. The groups treated with AEF and 





Table 9. Effects of the oral administration of AEF on the lipid peroxidation markers (Hydroperoxide or ROOH and Malondialdehyde or MDA contents) of different tissues homogenates and 
plasma  
 
 ROOH (μM) MDA (µM) 
                                                           Organs 
 Groups (n = 4) Liver Pancreas Plasma kidney Liver Pancreas Plasma kidney 
NC: Distilled water Normoglycae-mic rats 20.04±0.90
a 6.67±0.14 a 7.85±0.86 b 10.76±0.96 ab 4.28±0.34 a 2.81±0.30 b 2.92±0.32 ab 4.48±0.34c 
PC: Distilled water 
 
Diabetic rats 
17.73±0.45a 8.10±0.78 ab 17.88±0.79 a 9.37±0.82 bc 4.35±0.20 a 3.56±0.30 b 3.33±0.16 a 5.74±0.32 b 
FOR:AEF (250mg/kg bw) 16.32±0.78a 8.18±0.83 bc 4.88±0.43c 10.53±0.41ab 3.58±0.21 b 2.22±0.30 c 2.65±0.13 b 5.80±0.20 b 
FOR-DAO: AEF (250mg/kw 
bw) + Glibenclamide (3mg/kg 
bw) 
18.14±0.40a 8.83±1.06 bc 6.17±7.68 b 10.25±0.49 ab 3.52±0.27 b 2.61±0.10bc 2.63±0.25 b 6.46±0.46 b 
DAO: Glibenclamide 
(3mg/kg bw) 18.66±0.46
a 9.69±0.58 c  9.44±0.90 b 8.18±0.93 c 3.64±0.25 b 2.70±0.13 bc 2.57±0.21 b 5.45±0.25 b 
SAU: AES (250mg/kg bw) 14.98±0.27b 8.95±0.40bc 5.62±0.62b 9.90±0.50ab 3.84±0.22ab 3.74±0.30 a 2.68±0.08b 4.08±0.24 c 
 
The means followed by different letters (a, b, c, d) in the same column are significantly different at 5% level.  




MDA in the liver, pancreas and haemolysate 
compared to the PC group. There was no change 
between animals treated with AEF, AEF-
Glibenclamide and Glibenclamide in the other 
studied organs.  
The decrease in the level of MDA and constant 
contents of ROOH were also reported for T. 
tetraptera extracts (Bella  et al., 2012; Atawodi et 
al., 2014). According to them, the reduction of 
those markers can be attributed to the presence 
of bioactive compounds in plant extracts that trap 
and destroy ROS. It has been reported for this 
purpose that the amount and type of 
phytochemicals present in plants are largely 




Effect of AEF on liver damage markers 
 
The diabetes induced did not affect the total  
protein content (Figure 5) between the controls in 
all organ homogenates, plasma samples and 
haemolysates. In diabetic rats treated with 
Glibenclamide, AEF and AEF-Glibenclamide, the 
protein content in the liver, pancreas and kidneys 
was not different from that registered in the NC 
group. With regard to the plasma transaminases 
activities, Table 8 shows that there is no 
significant difference at the 5% threshold for the 
plasma ALT activities of different groups. 
However, only Glibenclamide led to a significant 
decrease in AST activity. The results obtained in 
the liver and plasma are similar to those reported 
by Taheri et al. (2012) cited by  Karami et al. 
(2016) while testing the effects of hydro-alcolohic  
extract of Berberis vulgaris root on the activity of 
liver enzymes in male hypercholesterolemic rats. 
These effects may be due to the hypoglycaemic 
activity of Glibenclamide and AEF and/or the 
regulation of glucose homeostasis and its use by  
peripheral tissues.  
The presence of flavonoids in both plant species 
also appears to be a contributing factor for 
maintaining protein levels in diabetic rats. This 
suggestion is supported by a report where the 
same effect was noted in diabetic rats treated with 
resveratrol (Palsamy and Subramanian, 2008). 
However, total protein content was reduced in 
several groups (livers of SAU group, pancreas 
and hemolysates of FOR-DAO). This could be 
due to the fact that the lack of insulin during 
diabetes may cause protein catabolism (Konrad et 
al., 2001). The increase in total protein according 
to the previous authors can be explained by the 
diabetogenic actions of STZ (DNA alkylation and 
increased O-glycosylated proteins rates in the β-
pancreatic cells). With regard to transaminase 
activities in plasma, their increase correlates with 
important gluconeogenesis and ketogenesis 







Figure 5. Total protein content (mg/mL) in various target organs.Means followed by different letters (a, b, c, d) for the same organ are significantly different at 5% level. NC: 
Normoglycaemic rats; PC: Diabetic rats receiving distilled water; FOR: Diabetic rats receiving AEF; FOR-DAO: Diabetic rats receiving AEF and Glibenclamide; DAO: Diabetic rats 




In this case, the induction of diabetes did not 
affect their activity. However, there was a non-
significant decrease compared to controls in the 
groups receiving AEF and AES. The plasma 
transaminase activities allow us to conclude that 
AEF at this concentration after 14 days of 
treatment shows no toxic effects in spite of the 
damage induced by STZ. These results are 
identical to those obtained previously (Ghorbani 
and Esmaeilizadeh, 2017) in obese diabetic rats 





In summary, the beneficial effects of AEF alone 
against metabolic disturbances associated with 
diabetes were observed. The action of 
Glibenclamide is improved by adding AEF, and 
AEF alone also has an equal influence on 
Glibenclamide for a few tests. Similar results were 
obtained with AEF and AES for a number of tests. 
For all of these observations, AEF possess a 
significant non-negligible potential; using only the 
anti-diabetic drugs was not sufficient to limit 
diabetes complications. We believe that AEF can 
be used as a food additive and can help to 
improve the effectiveness of oral anti-diabetic 
agents in order to delay the onset of degenerative 
complications in a controlled and regulated 
framework mechanism. However, the in vivo 
relevance of the anti-diabetic infusion should be 
more highly emphasised. Toxicological studies 
according to the administered dose should be 
highlighted in comparison with the administration 





Bw, Body weight; Dw, dry weight; AEF, Aqueous  
Extract of Tetrapleura tetraptera/Aframomum 
citratum formulation 95/5); AES, Aqueous Extract 
of Salvia Officinalis; ALT, Alanine 
Aminotransferase; AST, Aspartate 
Aminotransferase; DAD, Diode Array Detector; 
HPLC, High Performance Liquid Chromatography; 
IU, International Units; MDA,Malondialdehyde; 
RH,Relative humidity; ROOH,Hydroperoxides; 
ROS, Reactive Oxygen Species; rpm, revolutions 
per minute; SS, Starch Solution; SOD, Superoxide 
Dismutase; STZ,Streptozotocin; T2D, type 2 
diabetes; TFL, Total Flavonoid; TPP, Total 
Polyphenol; TAC, Total Antioxidant Capacity; NC, 
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